Sera Prognostics (SERA) Change in Account Payables (2020 - 2026)
Sera Prognostics posted quarterly Change in Account Payables of -$70000.0 for Q1 2026, up 92.97% year-on-year from -$36274.7 in Q1 2025, and up 25.53% on a QoQ basis from -$94000.0 in Q4 2025.
Sera Prognostics (SERA) has 7 years of Change in Account Payables data on file, last reported at -$70000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 92.97% year-over-year to -$70000.0; the trailing twelve-month figure through Mar 2026 stood at -$83000.0 (up 83.85% YoY), and the FY2025 full-year result was -$1.0 million, down 321.76% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$70000.0, up from -$94000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $556000.0 in Q4 2022 and bottomed at -$996000.0 in Q1 2025.
- The 5-year median for Change in Account Payables is -$15000.0 (2024), against an average of -$42000.0.
- The widest annual swing landed in 2022, when Change in Account Payables surged 554.12%; it then slumped 3588.89% in 2025.
- A 5-year view of Change in Account Payables shows it stood at $556000.0 in 2022, then plunged by 132.37% to -$180000.0 in 2023, then jumped by 312.22% to $382000.0 in 2024, then sank by 124.61% to -$94000.0 in 2025, then grew by 25.53% to -$70000.0 in 2026.
- The last three Change in Account Payables figures came in at -$70000.0 (Q1 2026), -$94000.0 (Q4 2025), and $52000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Sera Prognostics | 30.02 Mn | 30.02 Mn | -28,000.00 | -70,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -70,000.00 |
| Mar 31, 2026 | -70,000.00 |
| Dec 31, 2025 | -94,000.00 |
| Dec 31, 2025 | -94,000.00 |
| Sep 30, 2025 | 52,000.00 |
| Sep 30, 2025 | 52,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Mar 31, 2025 | -996,000.00 |
| Mar 31, 2025 | -996,000.00 |
| Dec 31, 2024 | 382,000.00 |
| Dec 31, 2024 | 382,000.00 |
| Sep 30, 2024 | 115,000.00 |
| Sep 30, 2024 | 115,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Mar 31, 2024 | -27,000.00 |
| Mar 31, 2024 | -27,000.00 |
| Dec 31, 2023 | -180,000.00 |
| Dec 31, 2023 | -180,000.00 |
| Sep 30, 2023 | 27,000.00 |
| Sep 30, 2023 | 27,000.00 |
| Jun 30, 2023 | -284,000.00 |
| Jun 30, 2023 | -284,000.00 |
| Mar 31, 2023 | -5,000.00 |
| Mar 31, 2023 | -5,000.00 |
| Dec 31, 2022 | 556,000.00 |
| Dec 31, 2022 | 556,000.00 |
| Sep 30, 2022 | 280,000.00 |
| Sep 30, 2022 | 280,000.00 |
| Jun 30, 2022 | -232,000.00 |
| Jun 30, 2022 | -232,000.00 |
| Mar 31, 2022 | -252,000.00 |
| Mar 31, 2022 | -252,000.00 |
| Dec 31, 2021 | 85,000.00 |
| Dec 31, 2021 | 85,000.00 |
| Sep 30, 2021 | 321,000.00 |
| Sep 30, 2021 | 321,000.00 |
| Jun 30, 2021 | -142,000.00 |
| Jun 30, 2021 | -142,000.00 |
| Mar 31, 2021 | 339,000.00 |
| Mar 31, 2021 | 339,000.00 |
| Dec 31, 2020 | -141,000.00 |
| Dec 31, 2020 | -141,000.00 |
| Sep 30, 2020 | 116,000.00 |
| Sep 30, 2020 | 116,000.00 |